Status:
COMPLETED
The Impact of the COVID-19 Pandemic on Cardiovascular Risk Factors in Patients With Diabetes
Lead Sponsor:
University Hospital Ostrava
Conditions:
Diabetes Mellitus
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to compare cardiovascular risk factors in patients with diabetes before the start of the pandemic of the COVID 19 (time 1 - T1), after 1 year (time 2 - T2) and 2 years (...
Detailed Description
Diabetes mellitus (DM) is one of the major risk factors of cardiovascular diseases (CVDs), which are the leading cause of death globally. To reduce overall cardiovascular risk in patients with diabete...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Diabetes mellitus of any type
- Planned visit to the outpatient diabetic clinic between 1.4. and 31.7.2021 - T2 (creation of the study group) - University hospital Ostrava, Czech Republic
- Known values of blood pressure, glycated haemoglobin, LDL cholesterol and BMI before the start of the pandemic (1.3.2020), not older than 6 months and no later than 31.3.2020.
- Signed consent to the use of anonymous data for scientific purposes and publications.
Exclusion
- failure to meet the criteria for inclusion
Key Trial Info
Start Date :
April 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04879251
Start Date
April 26 2021
End Date
August 31 2022
Last Update
December 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ostrava
Ostrava, Czechia, 70852